Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Treatment of Frontal Lobe Epilepsy
IRCT20210608051515N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cannabidiol in frontal lobe epilepsy (FLE) and epilepsy, sponsored by Tehran University of Medical Sciences. Started Jul 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
frontal lobe epilepsy (FLE)epilepsy
Beyond the preview
Go deeper on IRCT20210608051515N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210608051515N1.